ATE507285T1 - Prostata zellinien und deren verwendung - Google Patents

Prostata zellinien und deren verwendung

Info

Publication number
ATE507285T1
ATE507285T1 AT01917257T AT01917257T ATE507285T1 AT E507285 T1 ATE507285 T1 AT E507285T1 AT 01917257 T AT01917257 T AT 01917257T AT 01917257 T AT01917257 T AT 01917257T AT E507285 T1 ATE507285 T1 AT E507285T1
Authority
AT
Austria
Prior art keywords
cell lines
prostate
disease
prostate cell
onycap23
Prior art date
Application number
AT01917257T
Other languages
English (en)
Inventor
Peter Thraves
Andrew Sutton
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0008032A external-priority patent/GB0008032D0/en
Priority claimed from GB0024237A external-priority patent/GB0024237D0/en
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Application granted granted Critical
Publication of ATE507285T1 publication Critical patent/ATE507285T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01917257T 2000-04-01 2001-03-30 Prostata zellinien und deren verwendung ATE507285T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008032A GB0008032D0 (en) 2000-04-01 2000-04-01 New prostate cell lines
GB0024237A GB0024237D0 (en) 2000-10-03 2000-10-03 New prostate cell lines
PCT/GB2001/001437 WO2001075073A2 (en) 2000-04-01 2001-03-30 Prostate cell lines and their use

Publications (1)

Publication Number Publication Date
ATE507285T1 true ATE507285T1 (de) 2011-05-15

Family

ID=26244016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917257T ATE507285T1 (de) 2000-04-01 2001-03-30 Prostata zellinien und deren verwendung

Country Status (8)

Country Link
US (1) US7303911B2 (de)
EP (1) EP1272617B1 (de)
AT (1) ATE507285T1 (de)
AU (1) AU2001244341A1 (de)
CA (1) CA2404388C (de)
DE (1) DE60144515D1 (de)
DK (1) DK1272617T3 (de)
WO (1) WO2001075073A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
DE102004038076A1 (de) * 2004-02-16 2005-09-01 Proteosys Ag Diagnostische Marker für Krebs
TW202134430A (zh) 2019-12-03 2021-09-16 美商紐沃進公司 腫瘤細胞疫苗

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018296A1 (en) 1995-11-15 1997-05-22 University Of Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
JP2000502711A (ja) 1995-12-28 2000-03-07 ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オブ メディシン 同種異系パラクリンサイトカイン腫瘍ワクチン
WO1997028255A1 (en) 1996-02-02 1997-08-07 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
ATE229810T1 (de) 1996-10-11 2003-01-15 Univ California Krebs immuntherapie unter verwendung von tumorzellen kombiniert mit lymphozytmischungen
US5804443A (en) * 1997-02-28 1998-09-08 Bernofsky; Carl Human monocytic leukemia cell line
AU9794698A (en) 1997-10-10 1999-05-03 Regents Of The University Of California, The Enhanced immunogenic cell populations prepared using h2 receptor antagonists
DE19832840C1 (de) 1998-07-21 2000-06-08 Kerkmann Tucek Aida Mittel zur Immuntherapie von Tumorerkrankungen
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
JP2003500366A (ja) * 1999-05-21 2003-01-07 オニバックス リミティド 新規ワクチン製剤２

Also Published As

Publication number Publication date
DK1272617T3 (da) 2011-08-22
HK1052531A1 (en) 2003-09-19
AU2001244341A1 (en) 2001-10-15
CA2404388A1 (en) 2001-10-11
WO2001075073A3 (en) 2002-02-14
EP1272617A2 (de) 2003-01-08
US7303911B2 (en) 2007-12-04
US20030185808A1 (en) 2003-10-02
DE60144515D1 (de) 2011-06-09
CA2404388C (en) 2010-06-15
EP1272617B1 (de) 2011-04-27
WO2001075073A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
SV2002000019A (es) Estructura y metodo de fabricacion de tuberias
EP1546174A4 (de) Verfahren und zusammensetzungen für rna-interferenz
WO2002065565A3 (en) Flow field plate geometries
NO20010843D0 (no) Subtile mitokondrie mutasjoner som tumormarkører
DE60144515D1 (de) Prostata zellinien und deren verwendung
FR2749022B1 (fr) Cellules aviaires immortelles
NO20015157D0 (no) Fremgangsmåte ved bestemmelse av pre-noeplastiske og/eller neoplastiske tilstander hos pattedyr
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
EP1450602A4 (de) Identifizierung und charakterisierung von genen
DK1064018T3 (da) Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
ATE441710T1 (de) Antisense oligonukleotide, die die ausprägungsstufe von hif-1 hemmen
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
El Demellawy et al. Sebaceoma of the external ear canal: an unusual location. Case report and review of the literature
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
ATE249834T1 (de) Cyclosporin-lösung
Steel Exploring the materiality of water in Bronze Age Cyprus
Kone A two-sector analysis of devaluation in a small open economy with a sector-specific wage rigidity.
WO2003106626A3 (en) Method of cell growth inhibition with agnoprotein
SE9602100D0 (sv) New pharmaceuticals
Timmermans Two New Fluted Point Discoveries from Middlesex and Oxford Counties, Southwestern Ontario, Canada
Yuk-Kwan et al. Spindle Cell Carcinoma of the Tongue: Case report and immunohistochemical study
Rosenfeld " A noble house in the city": Domestic architecture as elite signification in late 19th century Hamilton (Ontario)
Luo et al. Expression of myopodin induces suppression of tumor growth and metastasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties